Clinical trials: Late Complication From Kidney Transplant
Late Complication From Kidney Transplant
Tocilizumab for Renal Graft Inflammation
Randomized open label clinical trial in which 48 renal transplant recipients with inflammation in the 6 month allograft biopsy will either continue usual immunosuppression or receive monthly Actemra (Tocilizumab) infusions for 6…
- Trial name
- NCT02108600
- Testing
- Tocilizumab
- Where
- United States
- Volunteers
- 33 people
- Sponsor
- Flavio Vincenti